๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
NATCO Pharma Limited (BOM:524816)
India flag India ยท Delayed Price ยท Currency is INR
817.00
-4.50 (-0.55%)
At close: Nov 20, 2026

NATCO Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
30,92440,81844,31940,02027,08519,462
Revenue Growth
-29.56%-7.90%10.74%47.76%39.17%-5.34%
Gross Profit
24,29533,46837,04532,53320,54113,617
Operating Income
5,66412,58519,66215,7068,0981,234
Net Income
8,28514,18518,85413,8837,1531,700
Earnings Per Share
46.2679.20105.2677.3439.189.32
EPS Growth
-46.15%-24.76%36.10%97.40%320.39%-61.42%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Pharmaceuticals
29,36139,40143,68938,90526,66219,399
Agro Chemicals
1,5281,3826061,08340949
Total
30,88940,78344,29539,98827,07119,448

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
15,17321,24524,89913,9127,9317,599
Total Debt
10,3347,1392,7943,8611,7614,320
Net Cash (Debt)
4,83914,10622,10510,0516,1703,279
Net Cash Growth
-83.56%-36.19%119.93%62.90%88.17%-38.57%
Net Cash Per Share
27.0278.76123.4256.0033.8017.98

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
7,42717,68316,96812,1168,491465
Capital Expenditures
-5,106-3,883-4,011-3,394-1,463-2,328
Free Cash Flow
2,32113,80012,9578,7227,028-1,863
Free Cash Flow Growth
-82.65%6.51%48.55%24.10%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
78.56%81.99%83.59%81.29%75.84%69.97%
Operating Margin
18.32%30.83%44.37%39.25%29.90%6.34%
Pretax Margin
28.91%37.66%51.70%41.82%31.82%10.39%
Profit Margin
26.79%34.75%42.54%34.69%26.41%8.73%
FCF Margin
7.51%33.81%29.24%21.79%25.95%-9.57%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
4.2505.0006.0009.5005.5004.500
Dividend Per Share Growth
21.43%-16.67%-36.84%72.73%22.22%-14.29%
Dividend Yield
0.52%0.51%0.75%1.00%0.98%0.60%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
17.6612.307.5912.2814.3781.18
P/FCF Ratio
68.8212.6411.0419.5514.63-
PS Ratio
5.174.283.234.263.807.09